CT-based habitat radiomics for predicting treatment response to neoadjuvant chemoimmunotherapy in esophageal cancer patients
2024

Using CT Scans to Predict Treatment Response in Esophageal Cancer

Sample size: 112 publication Evidence: high

Author Information

Author(s): Kong Weibo, Xu Junrui, Huang Yunlong, Zhu Kun, Yao Long, Wu Kaiming, Wang Hanlin, Ma Yuhang, Zhang Qi, Zhang Renquan

Primary Institution: First Affiliated Hospital of Anhui Medical University

Hypothesis

Habitat analysis can predict the effect of neoadjuvant therapy for esophageal cancer.

Conclusion

The study found that a model based on habitat data outperforms traditional radiomic analysis models in predicting treatment response.

Supporting Evidence

  • The model based on habitat data significantly improves predictive accuracy for treatment response.
  • AUC of habitat models was 0.909 in training and 0.829 in external test cohorts.
  • The nomogram model showed an AUC of 0.914 in training and 0.849 in test cohorts.

Takeaway

Doctors can use special scans to see how well treatment works for patients with esophageal cancer, helping them make better decisions.

Methodology

This was a two-center retrospective clinical study using pretreatment CT scans of patients with esophageal cancer treated with neoadjuvant chemoimmunotherapy.

Potential Biases

Manual tumor segmentation by different experts may affect the stability of radiomic features.

Limitations

The study is retrospective, which may introduce selection bias and affect sample representativeness.

Participant Demographics

Patients with biopsy-proven resectable esophageal cancer, treated with neoadjuvant chemoimmunotherapy.

Statistical Information

P-Value

0.014

Confidence Interval

0.8418–0.9758

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fonc.2024.1418252

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication